Provide feedbackProvide feedback
Home :: Infectious Disease

Prophylactic cephalosporin for urinary reflux increases risk of extended-spectrum beta-lactamase-producing bacteria for breakthrough UTIs

Tuesday, December 16 2008 | Comments
Evidence Grade 3 What's This?

Children with vesicoureteral reflux (VUR) receiving cephalosporin prophylaxis are at an increased risk of having extended-spectrum beta-lactamase (ESBL)-producing bacteria or multidrug-resistant uropathogens for breakthrough urinary tract infections (UTIs), a new retrospective study concludes. Researchers in Taiwan sought to examine bacterial antimicrobial resistance of recurrent UTIs in children receiving antibiotic prophylaxis because of primary VUR. To do so, they analyzed data...

Children with vesicoureteral reflux (VUR) receiving cephalosporin prophylaxis are at an increased risk of having extended-spectrum beta-lactamase (ESBL)-producing bacteria or multidrug-resistant uropathogens for breakthrough urinary tract infections (UTIs), a new retrospective study concludes.

Researchers in Taiwan sought to examine bacterial antimicrobial resistance of recurrent UTIs in children receiving antibiotic prophylaxis because of primary VUR. To do so, they analyzed data retrospectively for pediatric patients at 2 tertiary medical centers, the Chang Gung Children's Hospital (CGCH) and the National Taiwan University Hospital (NTUH), selecting as participants patients with a confirmed diagnosis of primary VUR and who had developed breakthrough UTIs during the prophylaxis period.

At CGCH, the researchers enrolled 324 patients who had received prophylactic antibiotic therapy for >=3 months before surgery or >=6 months without surgery during the period of January 2001 through December 2002. Of these patients, 109 received trimethoprim/sulfamethoxazole, 100 received cephalexin, 44 received cefaclor, and 71 received 2 to 3 kinds of prophylactic antibiotics sequentially (alternative monotherapy). During the same period, the team enrolled 96 children at NTUH using the same criteria. These patients all received trimethoprim/sulfamethoxazole prophylaxis. Follow-up lasted 5 years.

Children at both hospitals experienced breakthrough UTIs (20.4% at CGCH and 25.0% at NTUH). Escherichia coli infection was significantly less common for breakthrough UTIs compared with initial episodes of UTI, a finding supported by earlier studies, according to the authors. This was true at both hospitals (CGCH relative risk [RR] for a pathogen other than E. coli for breakthrough UTIs, 3.0; 95% CI, 2.1-4.3; P<.0001; NTUH RR, 2.3; 95% CI, 1.4-3.8; P=.003).

Children receiving cephalexin or cefaclor prophylaxis were more likely to have ESBL-producing bacteria compared with children receiving trimethoprim/sulfamethoxazole prophylaxis (RR, 9.8; 95% CI, 1.3-73.3; P=.005). This cephalosporin effect on ESBL-producing bacteria and pathogens other than E. coli was still present and dominant in children with alternative monotherapy who received a sequence of different antibiotics including trimethoprim/sulfamethoxazole, cephalexin, and cefaclor (P=.06 for ESBL-producing organisms and P=.01 for pathogens other than E. coli, compared with trimethoprim/sulfamethoxazole). Furthermore, antimicrobial susceptibilities to almost all antibiotics decreased with cephalosporin prophylaxis when recurrent UTIs developed. Antimicrobial susceptibilities decreased minimally in the trimethoprim/sulfamethoxazole prophylaxis groups.

"The present study provides evidence to support the current recommendations that [trimethoprim/sulfamethoxazole] is appropriate for prophylaxis and that cephalosporins will not suffice," the authors concluded. (Cheng C-H, et al. Pediatrics 2008;122:1212-1217.)

Latest News

Costs, reimbursement of childhood vaccines appear to vary across private practices; high costs may prompt financial strain for providers Verusmed

Wednesday, December 10 2008 | Comments
Evidence Grade 9 What's This?
Private physician practices pay a wide range of prices for the same pediatric immunization products and are reimbursed at different levels, according to one recent study. A second study revealed high vaccine costs and unsatisfactory reimbursement levels may prompt financial burden for some providers.

In the first study, researchers from the University of Michigan led by Dr. Gary Freed surveyed a convenience sample of 76 practices in 5 states...

PCPs miss opportunities to vaccinate high-risk adolescents against influenza, researchers find Verusmed

Wednesday, December 03 2008 | Comments
Evidence Grade 11 What's This?
The vast majority of adolescents with high-risk medical conditions do not receive the influenza vaccination, data from a retrospective observational study suggest.

Noting that influenza affects 20% to 40% of children and adolescents each year, researchers at Harvard Medical School assessed influenza vaccination rates from 1992 to 2002 among adolescents aged 11 to 17 years who had >=1 high-risk medical condition (n=18,703). The study...


Laminar airflow ventilation during orthopedic, abdominal procedures does not prevent surgical site infections, study suggests Verusmed

Friday, November 07 2008 | Comments
Evidence Grade 4 What's This?
A large, retrospective study suggests that operating rooms (ORs) with laminar airflow ventilation do not prevent surgical site infections (SSIs) among patients undergoing abdominal or orthopedic surgery, and ORs with this type of ventilation may actually be associated with a significantly higher risk of severe SSIs following hip replacements as compared with ORs that use turbulent ventilation.

The study included data from 63 surgery departments in 55 German...

Researchers note 5-fold increase in S. aureus coinfection with pediatric influenza in 3 years Verusmed

Wednesday, October 29 2008 | Comments
Evidence Grade 10 What's This?
Pediatricians should be concerned with low influenza vaccination rates among children and aware of a significant increase in pediatric influenza deaths associated with Staphylococcus aureus coinfection, suggests a study of pediatric influenza-associated mortality in the United States.

Researchers with the Centers for Disease Control and Prevention reviewed data from case reports submitted to the center's influenza surveillance program, which since October 2004 has required...